Concepedia
2
Publications
47
Citations
H-Index
2024
Active since
Affiliations
Hubei Cancer Hospital(Current)
Third Affiliated Hospital of Harbin Medical University
BeiGene (China)
Harbin Medical University
Shuaiji Lu is an author at Hubei Cancer Hospital.
Publications per year
2024–2024
Tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: final analysis of the randomized, phase III RATIONALE-307 trial
Jie Wang, Shuaiji Lu, Xiaohua Yu et al. · ESMO Open · 2024 · 25 citations · Full text
Tislelizumab plus chemotherapy as first-line treatment of locally advanced or metastatic nonsquamous non-small-cell lung cancer (final analysis of RATIONALE-304: a randomized phase III trial)
Shuaiji Lu, Jiarui Wang, Yan Yu et al. · ESMO Open · 2024 · 22 citations · Full text
Rows per page
1–2 of 2